Public Awareness Committee

Chair: Mark Skaletsky, Cheif Executive Officer, Fenway Pharmaceuticals, Inc. 
Staff Contact: Kenneth Lisaius, Vice President, Communications, klisaius@bio.org

Subject Matter/Jurisdiction: The committee oversees BIO’s communications, media relations, website, public education, focus groups, and external outreach initiatives.

Roster:

Chairman:
Mark Skaletsky, Cheif Executive Officer, Fenway Pharmaceuticals, Inc.

Members:
Alexis Borisy, Chairman, Forma Therapeutics, Inc. 
Ron Cohen, President & CEO, Acorda Therapeutics, Inc.
Stanley Crooke, Chairman & CEO, Isis Pharmaceuticals
Douglas  Doerfler, President & CEO, MaxCyte, Inc.
David  Hale, Chairman, Micromet, Inc.
Paul  Hastings, President & CEO, OncoMed Pharmaceuticals, Inc
Perry Karsen, Chief Operations Officer, Celgene
Arlene Morris, Chief Executive Officer, Syndax
John  Orwin, Chief Executive Officer, Affymax, Inc.
David  Pyott, Chairman & CEO, Allergan, Inc.
Timothy  Rodell, President & CEO, GlobeImmune
Gerald  Steiner, Executive VP, Commercial Acceptance, Monsanto Company 
Robert Zerbe, Chief Executive Officer, QuatRx Pharmaceuticals, Inc.

Hide Date: 
Hide Date
Hide Add This: 
Hide Add This